Davies GR - Search Results

1

Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.

Sabiiti W, Mtafya B, Kuchaka D, Azam K, Viegas S, Mdolo A, Farmer EC, Khonga M, Evangelopoulos D, Honeyborne I, Rachow A, Heinrich N, Ntinginya NE, Bhatt N, Davies GR, Jani IV, McHugh TD, Kibiki G, Hoelscher M, Gillespie SH; PANBIOME (Pan-African Biomarker Expansion Programme) consortium. Sabiiti W, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 2016 Aug;20(8):1004-9. doi: 10.5588/ijtld.15.0951. Int J Tuberc Lung Dis. 2016. PMID: 27393531

2

Adaptive clinical trials in tuberculosis: applications, challenges and solutions.

Davies GR, Phillips PP, Jaki T. Davies GR, et al. Int J Tuberc Lung Dis. 2015 Jun;19(6):626-34. doi: 10.5588/ijtld.14.0988. Int J Tuberc Lung Dis. 2015. PMID: 25946350 Review.

3

Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.

Sloan DJ, Mwandumba HC, Kamdolozi M, Shani D, Chisale B, Dutton J, Khoo SH, Allain TJ, Davies GR. Sloan DJ, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 2015 Aug;19(8):904-11. doi: 10.5588/ijtld.15.0071. Int J Tuberc Lung Dis. 2015. PMID: 26162355 Free PMC article.

4

Methods for selecting regimen duration to prevent relapse in drug-susceptible and drug-resistant TB.

Davies GR, Wallis RS. Davies GR, et al. Int J Tuberc Lung Dis. 2016 Dec 1;20(12):13-17. doi: 10.5588/ijtld.16.0231. Int J Tuberc Lung Dis. 2016. PMID: 28240567

5

TB control programmes remain an important gateway to HIV diagnosis in the era of expanded access to HIV care.

McCallum AD, Sheha I, Chasweka M, Banda G, Davies GR, Khoo SH, Mwandumba HC, Sloan DJ. McCallum AD, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 2020 Jan 1;24(1):131-132. doi: 10.5588/ijtld.19.0504. Int J Tuberc Lung Dis. 2020. PMID: 32005317 No abstract available.

6

Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995.

Connolly C, Davies GR, Wilkinson D. Connolly C, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 1998 Nov;2(11):919-25. Int J Tuberc Lung Dis. 1998. PMID: 9848614

7

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T, Reddy C, Sturm AW, Sirgel FA, Allen J, Coleman DJ, Fourie B, Mitchison DA; Gatifloxacin for TB (OFLOTUB) study team. Rustomjee R, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 2008 Feb;12(2):128-38. Int J Tuberc Lung Dis. 2008. PMID: 18230244 Clinical Trial.

8

Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa.

Davies GR, Pillay M, Sturm AW, Wilkinson D. Davies GR, et al. Int J Tuberc Lung Dis. 1999 Sep;3(9):799-804. Int J Tuberc Lung Dis. 1999. PMID: 10488888

9

Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa.

Connolly C, Davies GR, Wilkinson D. Connolly C, et al. Among authors: davies gr. Int J Tuberc Lung Dis. 1999 Dec;3(12):1081-7. Int J Tuberc Lung Dis. 1999. PMID: 10599011

10

Optimal sampling strategies for early pharmacodynamic measures in tuberculosis.

Davies GR, Khoo SH, Aarons LJ. Davies GR, et al. J Antimicrob Chemother. 2006 Sep;58(3):594-600. doi: 10.1093/jac/dkl272. Epub 2006 Jul 19. J Antimicrob Chemother. 2006. PMID: 16857690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page